A/Prof Peter J Psaltis (MBBS (Hons), PhD, FRACP, FCSANZ, FESC)

Peter Psaltis is an academic interventional cardiologist and vascular biologist, who holds Faculty positions at SAHMRI, CALHN and the University of Adelaide. He is the Deputy Director of SAHMRI, co-leads its largest research department, the Lifelong Health Theme (>310 researchers), and leads its Heart and Vascular Program (>60 researchers). Concurrently, he is also Head of Interventional Cardiology, Royal Adelaide Hospital. Among other leadership positions, Psaltis is a Board Director of the Australian Cardiovascular Alliance, past-president of the Australian Atherosclerosis Society, co-chair of the South Australian Aboriginal Heart and Stroke Leadership Group, and co-chair of the National Heart Foundation’s South Australian Cardiovascular Research Network. He also has served on the Scientific Committee of the Cardiac Society of Australia and New Zealand, and was/is the national lead of the CLEAR Outcomes (Esperion) and SURMOUNT-MMO (Eli Lilly) clinical trials, and principal investigator of the COCOMO-ACS trial (NHMRC).

Psaltis has expertise across all three disciplines of basic, translational, and clinical research and leads bench-to-bedside projects spanning topics of developmental macrophage biology, vascular stem cells, inflammatory regulation of atherosclerosis, pharmacological modification of atherosclerosis, coronary plaque imaging, the modelling of biomechanical forces in coronary arteries and cardiometabolic disease. He currently holds a Level 3 National Heart Foundation Future Leader Fellowship and has received >$22 million of peer-reviewed grant funding. This includes 4 CIA NHMRC project/idea grants, one of which received the 2021 Marshall and Warren Award for Innovation. Psaltis has published >200 full-text manuscripts and has graduated 13 PhD (4 as principal supervisor, all Dean’s commendation, including one Doctoral Research Medal) and 11 Hons students (all first class).